U.S. Machinery Stock News

Why Sphere Entertainment’s latest earnings matter for investors Sphere Entertainment (SPHR) has drawn fresh attention after reporting second quarter and six month results that combine higher sales with a shift to net losses compared with the prior year period. The company also highlighted strong audience interest in its The Wizard of Oz at Sphere experience, which has brought in more than 3.6 million guests and supported ticket sales ahead of first anniversary celebrations starting August...

The market gave SandRidge Energy only a muted nod after earnings. The stock inched up about 1% to roughly US$13.60 even though the headline result was a punchy quarter of profit and production. Q2 net income landed near US$26.7 million, or about US$0.72 per share, powered by oil weighted volumes and unhedged oil realizations above US$95 per barrel. Coming into the release, you were looking at a stock that had slipped over the past week and quarter. Today’s modest bounce suggests investors are...

Terreno Realty stock barely budged after earnings, up less than 1% and still roughly flat over the past week. On the surface that looks like a shrug. The headline, however, is that this industrial REIT is reporting solid rental cash flow while carrying a complicated profit story. The key tension is between strong funds from operations per share of US$0.70 in the quarter and trailing earnings that were inflated by a one off gain of about US$210.9m. Add in a P/E near 19x and analysts projecting...

Warrior Met Coal stock closed up 2.6% at US$91.97, a calm move for a company that just put a very different story on the tape. The headline is simple. Q2 2026 marked a clean profit and cash flow step change, with net income of US$87.4 million and free cash flow of US$103 million, supported by record quarterly sales volume. Short term traders see a stock that has already run over the past month. Long term investors see a metallurgical coal producer that has moved firmly into free cash flow...

Portillo's stock barely budged after earnings, up just 1% to about US$4.43, even as the quarter put the company’s biggest pressure point into sharper focus. Same restaurant sales slipped 1.2% while restaurant level margins compressed, with food, beverage and packaging costs now at 35% of revenue. That is the short term story. The long term question is whether Portillo's can offset that cost squeeze through slower unit growth, a leaner store prototype and the US$10 to US$15 million of annual...

Allstate shareholders woke up to a reality check. The stock slipped almost 3% to about US$267 even though the insurer just printed another quarter of heavy profits and tight underwriting. Q2 adjusted earnings landed at US$8.99 per share, with net income of US$3.2b and a Property and Casualty combined ratio of 86.6%, which points to solid profitability for an insurer. The stock has run hard over the past three months and then cooled on the day, right as Allstate posted strong income and...

What the Raytheon SM-3 contract means for Voyager Technologies stock Voyager Technologies (VOYG) has drawn fresh attention after Raytheon, an RTX business, awarded the company a contract to supply propulsion and divert, attitude and control systems for the Standard Missile 3 interceptor family. This contract highlights Voyager Technologies’ role in solid propulsion and precision maneuvering systems for missiles and space payloads, which already sit at the core of its Defense & National...

Check Point Software Technologies (CHKP) drew investor attention after reporting second quarter 2026 results, issuing third quarter revenue guidance, launching its AI Network Firewall, and updating progress on a long running share repurchase plan. See our latest analysis for Check Point Software Technologies. The recent 1-day share price return of 2.03% and 7-day share price return of 0.54% suggest a short-term rebound after a 30-day share price return that declined 6.60%. However, the 1-year...

Ternium (NYSE:TX) stock is in focus after Q2 2026 results showed higher sales, an increase in adjusted EBITDA margin to 16.5%, and an earnings surprise versus analyst expectations. See our latest analysis for Ternium. The Q2 earnings surprise and margin improvement appear to have reinforced interest in Ternium, with the share price at US$51.89 after a 21.38% 1 month share price return and a 75.22% 1 year total shareholder return, suggesting momentum has been building. If the recent move in...

With the US unexpectedly losing 23,000 jobs in July and wage growth slowing while inflation sits at 3.5%, shoppers may start stretching every dollar. That shift in behavior can matter a lot for certain stocks that are tied to value focused spending. This article walks through three stocks from our Discount Retailers and Value Chains screener that appear particularly exposed to these labor market and inflation trends. The three stocks covered below are just a small sample, and the full screen...

Cintas (NasdaqGS: CTAS) announced a leadership change, appointing Jim Rozakis as President while Todd Schneider continues as CEO. The company has formally separated the President and CEO roles, signaling a new executive structure for the business. Consider broadening your watchlist with other companies in similar industries through 78 resilient stocks with low risk scores NasdaqGS:CTAS 1-Year Stock Price Chart Cintas operates in the uniform rental and facility services space, an area that...

Collegium Pharmaceutical stock has delivered a 59.8% gain over the past five years, yet the recent share price pullback and a strong set of valuation checks suggest the market may be reassessing how cheap or expensive the current price really is. Over five years, Collegium Pharmaceutical has returned 59.8%, which points to meaningful value creation for longer term holders despite more recent weakness. Future growth in prescriptions and cash flow can support the current market value, while...

Amylyx Pharmaceuticals (AMLX) shares moved after the company reported second quarter 2026 results, which showed a net loss of US$43.42 million and basic loss per share from continuing operations of US$0.39. See our latest analysis for Amylyx Pharmaceuticals. The latest earnings update appears to have sharpened attention on Amylyx Pharmaceuticals, with the share price at US$24.19 and a 1-day share price return of 10.71%, building on a 30-day share price return of 33.13% and a 1-year total...

H2O America stock has delivered a 27.2% return over the past year, yet the latest valuation work, including the Dividend Discount Model (DDM) intrinsic value estimate and earnings-based multiples, both suggest the shares trade at a premium rather than at a discount. Over the last 12 months H2O America is up 27.2%, which puts recent shareholders in profit while raising the question of how much optimism is already in the price. Expectations around growth from the planned Quadvest acquisition...

HF Sinclair stock has more than tripled over the past five years, yet its valuation checks still lean cheap, which raises a clear question over how much of that past share price strength is already reflected in today's price. With investors also weighing the planned separation of the Lubricants & Specialties segment and the closure of Canada's largest base oil refinery, the current market value is under close scrutiny. HF Sinclair has delivered a 224.8% return over the last five years, which...

Why Getty Realty’s New Accounting Chief Matters For Investors Getty Realty (GTY) has announced a leadership change in its finance function, appointing Nicole Rapport as Vice President and Chief Accounting Officer as of August 16, 2026, replacing long-time executive Eugene Shnayderman. The company states that Shnayderman’s departure does not stem from disagreements over accounting principles, financial reporting, or disclosure. For investors tracking governance and reporting quality, this...

Why Corcept Therapeutics stock is back in focus after Q2 earnings Corcept Therapeutics (CORT) is drawing fresh attention after its July 29 earnings update, which paired detailed second quarter results with higher full year 2026 revenue guidance and a buyback progress report. See our latest analysis for Corcept Therapeutics. Corcept Therapeutics’ share price has eased in the very short term, with a 1 day share price return of 2.48% and a 7 day share price return of 8.76%. However, the 30 day...

With the US economy unexpectedly losing 23,000 jobs in July and rate hike expectations cooling, the market mood has shifted fast. That kind of shock can punish some stocks and quietly set up others for their next chapter. This article walks through three growth stocks from our screener that are closely tied to this news, so you can see where investors may be leaning in or stepping back next. The three stocks below are just a sample, while the full growth screen surfaced 46 more larger...

In early August 2026, Commerce.com, Inc. reported second-quarter results showing sales of US$84.51 million and a return to profitability, while also lowering its full-year 2026 revenue guidance to US$336.5 million–US$344.5 million, implying performance around flat compared with 2025 revenue of US$342.3 million. This mix of improved earnings and a more cautious revenue outlook contrasts with recent partnership wins, including new collaborations with WP Engine and Waterco that expand the reach...

With the Federal Reserve keeping interest rates parked at 3.5% to 3.75% and inflation still above target, income investors face a puzzle. Cash yields look appealing, yet high borrowing costs can quietly stress parts of the market. This article focuses on how that backdrop connects to high quality dividend stocks and reveals three companies from our screener that appear better positioned to handle stubbornly high rates. The three dividend stocks highlighted next are just a starting sample,...

The Hanover Insurance Group, Inc. reported past second-quarter 2026 results with revenue of US$1,726.2 million and net income of US$191.6 million, both higher than a year earlier, and diluted earnings per share from continuing operations rising to US$5.37. These stronger earnings, alongside higher first-half 2026 profits and earnings per share, have been accompanied by upbeat analyst assessments highlighting improved momentum and value characteristics for the stock. With this stronger...

Metropolitan Bank Holding (NYSE: MCB) is under investigation by a law firm for potential federal securities law violations tied to recent financial disclosures. The inquiry follows the company's latest second quarter results, which included an earnings miss and a sharp rise in credit loss provisions linked to troubled loans. Investigators are reviewing whether Metropolitan Bank's public statements gave investors a full and accurate picture of its loan quality and associated risks. The probe...

Simpson Manufacturing Co., Inc. has already reported its second-quarter 2026 results, with sales rising to US$671.08 million and net income to US$127.04 million, while its board also declared a regular quarterly dividend of US$0.30 per share payable on October 22, 2026. The combination of higher earnings per share and the continued dividend highlights management’s focus on profitability and consistent capital returns despite softer housing activity. We’ll now examine how Simpson...

McEwen stock has delivered a 157.9% return over the past three years, yet the valuation checks paint a more mixed picture that stops short of calling it a clear bargain or clearly expensive at the current share price of US$18.26. Over the past three years, McEwen has returned 157.9%, which puts recent short-term moves into the context of a strong multi-year run. Recent progress on key gold and copper projects and new PhotonAssay laboratory capacity can support expectations for future...